Seizures increase prostaglandin and cytokine levels in the brain. However, it remains to be determined whether cyclooxygenase-2 (COX-2) derived metabolites play a role in seizure-induced cytokine increase in the brain and whether anticonvulsant activity is shared by all COX-2 inhibitors. In this study we investigated whether three different COX-2 inhibitors alter pentylenetetrazol (PTZ)-induced seizures and increase of interleukin-1β (IL-1β), interleukin-6 (IL-6), interferon-γ (INF-γ), tumor necrosis factor-α (TNF-α) and interleukin-10 (IL-10) levels in the hippocampus and cerebral cortex of mice. Adult male albino Swiss mice received nimesulide, celecoxib or etoricoxib (0.2, 2 or 20mg/kg in 0.1% carboxymethylcellulose (CMC) in 5% Tween 80, p.o.). Sixty minutes thereafter the animals were injected with PTZ (50mg/kg, i.p.) and the latency to myoclonic jerks and to generalized tonic-clonic seizures were recorded. Twenty minutes after PTZ injection animals were killed and cytokine levels were measured. PTZ increased cytokine levels in the cerebral cortex and hippocampus. While celecoxib and nimesulide attenuated PTZ -induced increase of proinflammatory cytokines in the cerebral cortex, etoricoxib did not. Nimesulide was the only COX-2 inhibitors that attenuated PTZ-induced seizures. This effect coincided with an increase of IL-10 levels in the cerebral cortex and hippocampus, constituting circumstantial evidence that IL-10 increase may be involved in the anticonvulsant effect of nimesulide.
Cysteinyl leukotrienes (CysLTs) have been implicated in seizures and kindling;
however, the effect of CysLT receptor antagonists on seizure frequency in kindled
animals and changes in CysLT receptor expression after pentylenetetrazol
(PTZ)-induced kindling have not been investigated. In this study, we evaluated
whether the CysLT1 inverse agonist montelukast, and a classical anticonvulsant,
phenobarbital, were able to reduce seizures in PTZ-kindled mice and alter CysLT
receptor expression. Montelukast (10 mg/kg, sc) and phenobarbital
(20 mg/kg, sc) increased the latency to generalized seizures in
kindled mice. Montelukast increased CysLT1 immunoreactivity only in
non-kindled, PTZ-challenged mice. Interestingly, PTZ challenge decreased
CysLT2 immunoreactivity only in kindled mice. CysLT1
antagonists appear to emerge as a promising adjunctive treatment for refractory
seizures. Nevertheless, additional studies are necessary to evaluate the clinical
implications of this research.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.